NSEAnalysts/Institutional Investor Meet/Con. Call Updates1h ago · 22 Jul 2026, 04:24 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Jagsonpal Pharmaceuticals Limited · JAGSNPHARM

✦ AI SummaryResults

Jagsonpal Pharmaceuticals Limited has scheduled a conference call with analysts and investors on July 30, 2026, to discuss its Q1 FY27 financial results.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Jagsonpal Pharmaceuticals Limited has informed the Exchange about Schedule of meet

Attachments (1)

📄

JAGSNPHARM_22072026162407_IntimationInvestorMeet.pdf

pdf

Download →
View document text
Jagsonpal Pharmaceuticals Ltd ( ::.:&.mu • -~ Sakht Corporate Office: Plot No. 412-415, Nimai Tower, 3rd Floor, Phase-IV, Udyog Vihar, Sector-18, Gurugram -122015, Haryana (India) Ph.: +91124 4406710; E-mail: info@jagsonpal.com; Website: www.jagsonpal.com A CSR Initiative lJAGSONPAL! CIN. : L74899DL1978PLC009181 July 22, 2026 The Department of Corporate Services- Listing The Department of Corporate Services- Listing BSE Ltd, National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street Bandra Kurla Complex, Mumbai-400 001 Bandra (E) Mumbai – 400 051 Scrip Code: 507789 Symbol: JAGSNPHARM Subject: Intimation of Analysts/ Investors Conference call Dear Sir/ Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company, as a part of its investors engagement activities, has scheduled a conference call with the Analysts / Investors on Thursday, July 30, 2026, to discuss its Q1 FY27 financial results. The Conference call details is attached as Annexure. We request you to take the above on record. Thanking you, Yours faithfully, For Jagsonpal Pharmaceuticals Limited Pratham Rawal Company Secretary & Compliance Officer Encl.: A/a Regd. Office: Innov8, 3rd Floor, Plot No. 211, Okhla Phase-3, New Delhi-110020 (India) Mumbai Office: 13-14, Unit 3B, Phoenix Paragon Plaza, Kurla West, Mumbai, Maharashtra- 400070 Go India Advisors JAGSONPAL Jagsonpal Pharmaceuticals Limited Q1FY27 Earnings Conference Call Hosted by Go India Advisors Company Participants Thursday, 30th July 2026 IST 2:30 PM Call in Details: Pre-register to avoid wait time, join with Diamond Pass. Registration link: CLICK HERE Dial in Numbers: Please dial-in at least 5-10 minutes prior to the conference call schedule to ensure that you are connected to the call on time Universal Dial-In Numbers +91 22 6280 1557 / +91 22 7115 8383 For further information, kindly contact: Soumya Chhajed Sheetal Khanduja soumya@goindiaadvisors.com sheetal@goindiaadvisors.com